By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and Plenus today announced the formation of a new firm, Agradis, to develop and commercialize products that leverage new technologies in genomics and plant breeding.

The companies also announced Agradis has raised $20 million in a Series A financing round to establish a corporate infrastructure and to support product development and commercialization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.